Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350233 · ClinicalTrials.gov registry record · Phase 1
MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors
A Phase 1 study, sponsored by InSightec.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00350233 is a Phase 1 study that has completed, run by InSightec. The registered enrollment target is 10 participants.
The verdict
NCT00350233, a Phase 1 study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this trial is to evaluate the safety and effectiveness of MRgFUS in the treatment of metastatic bone tumors.
Interventions
- DEVICE ExAblate 2000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-05 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350233
The ClinicalTrials.gov registry entry for NCT00350233 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExAblate 2000 is the first listed.
NCT00350233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350233 about?
NCT00350233 is a clinical study titled "MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors". The objective of this trial is to evaluate the safety and effectiveness of MRgFUS in the treatment of metastatic bone tumors.
What is the current status of trial NCT00350233?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2006-05. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00350233?
The interventions under investigation include: ExAblate 2000 (DEVICE).
Who is sponsoring clinical trial NCT00350233?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.